Does a 78-year-old man with acute urinary retention after a hip fracture need a Prostate-Specific Antigen (PSA) test or Digital Rectal Examination (DRE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Urinary Retention in an Elderly Man After Hip Fracture

A 78-year-old man with acute urinary retention following hip fracture does not routinely need a PSA test or DRE at this time, as the retention is likely related to the acute trauma and perioperative factors rather than underlying prostate pathology.

Etiology of Acute Urinary Retention After Hip Fracture

  • Acute urinary retention is extremely common in hip fracture patients, with incidence rates as high as 82% before surgery and 56% after surgery 1
  • The retention is typically related to trauma, pain, immobility, medications (especially opioids and anesthetics), and the stress response to injury rather than underlying prostate pathology 1, 2
  • Fecal impaction is strongly associated with postoperative urinary retention after hip fracture surgery (OR 4.78,95% CI 2.44-9.71) and should be assessed 3

Initial Management Approach

  • The priority should be bladder decompression to prevent complications, using either:

    • Intermittent catheterization (preferred) - associated with earlier return to normal voiding (mean 5.1 days vs 9.4 days with indwelling catheters) 4
    • Indwelling catheter - should be removed within 24-48 hours after surgery to reduce risk of urinary tract infection and prolonged retention 2, 5
  • Urinalysis should be performed to screen for hematuria and urinary tract infection 6

When PSA Testing and DRE Are Indicated

  • PSA testing and DRE are not routinely indicated in the acute management of urinary retention after hip fracture 6

  • PSA testing should only be considered in the following circumstances:

    • Patients with at least a 10-year life expectancy for whom knowledge of prostate cancer would change management 6
    • Patients for whom PSA measurement may change the management of their voiding symptoms 6
    • After resolution of the acute episode and any urinary tract infection (as infection can falsely elevate PSA) 7
  • DRE should be considered only if:

    • There is suspicion of locally advanced prostate cancer causing obstruction 6, 8
    • As part of the evaluation of persistent lower urinary tract symptoms after recovery from hip fracture 6

Follow-up Recommendations

  • Monitor for resolution of urinary retention with trial of voiding after catheter removal 4
  • If retention persists beyond the expected recovery period (typically 5-10 days post-surgery), further urological evaluation may be warranted 1, 4
  • For patients with persistent lower urinary tract symptoms after recovery, a complete urological evaluation including DRE and consideration of PSA testing would be appropriate 6

Important Considerations

  • Urinary retention after hip fracture is primarily a consequence of the trauma and perioperative factors rather than an indication of underlying prostate disease 1, 2
  • Focusing on early mobilization, adequate pain control, and prevention of constipation can help reduce the duration of urinary retention 5, 3
  • Prolonged catheterization increases the risk of urinary tract infections and should be avoided 2, 4

References

Research

Management of urinary retention after surgical repair of hip fracture.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1992

Research

Hip fracture and urinary incontinence--use of indwelling catheter postsurgery.

Scandinavian journal of caring sciences, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Suspected Prostate Cancer and Upper Urinary Tract Pathology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Evaluation of Suspected Prostate Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.